Correlation Between Er Therapeutics and Innospec
Can any of the company-specific risk be diversified away by investing in both Er Therapeutics and Innospec at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Er Therapeutics and Innospec into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Er Therapeutics and Innospec, you can compare the effects of market volatilities on Er Therapeutics and Innospec and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Er Therapeutics with a short position of Innospec. Check out your portfolio center. Please also check ongoing floating volatility patterns of Er Therapeutics and Innospec.
Diversification Opportunities for Er Therapeutics and Innospec
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between PNGM and Innospec is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Er Therapeutics and Innospec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innospec and Er Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Er Therapeutics are associated (or correlated) with Innospec. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innospec has no effect on the direction of Er Therapeutics i.e., Er Therapeutics and Innospec go up and down completely randomly.
Pair Corralation between Er Therapeutics and Innospec
Given the investment horizon of 90 days Er Therapeutics is expected to generate 87.12 times more return on investment than Innospec. However, Er Therapeutics is 87.12 times more volatile than Innospec. It trades about 0.11 of its potential returns per unit of risk. Innospec is currently generating about 0.05 per unit of risk. If you would invest 0.01 in Er Therapeutics on October 9, 2025 and sell it today you would earn a total of 0.00 from holding Er Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 98.39% |
| Values | Daily Returns |
Er Therapeutics vs. Innospec
Performance |
| Timeline |
| Er Therapeutics |
| Innospec |
Er Therapeutics and Innospec Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Er Therapeutics and Innospec
The main advantage of trading using opposite Er Therapeutics and Innospec positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Er Therapeutics position performs unexpectedly, Innospec can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will offset losses from the drop in Innospec's long position.| Er Therapeutics vs. Americas Silver Corp | Er Therapeutics vs. Materion | Er Therapeutics vs. Boise Cascad Llc | Er Therapeutics vs. Skeena Resources |
| Innospec vs. Chemours Co | Innospec vs. Ingevity Corp | Innospec vs. Minerals Technologies | Innospec vs. Ashland Global Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |